Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Explicit feedback to enhance the effect of an interim assessment: a cross-over study on learning effect and gender difference.

Olde Bekkink M, Donders R, van Muijen GN, de Waal RM, Ruiter DJ.

Perspect Med Educ. 2012 Nov;1(4):180-91. doi: 10.1007/s40037-012-0027-y. Epub 2012 Sep 27.

2.

Challenging medical students with an interim assessment: a positive effect on formal examination score in a randomized controlled study.

Olde Bekkink M, Donders R, van Muijen GN, Ruiter DJ.

Adv Health Sci Educ Theory Pract. 2012 Mar;17(1):27-37. doi: 10.1007/s10459-011-9291-6. Epub 2011 Mar 27.

3.

Soluble adhesion molecules in human cancers: sources and fates.

van Kilsdonk JW, van Kempen LC, van Muijen GN, Ruiter DJ, Swart GW.

Eur J Cell Biol. 2010 Jun;89(6):415-27. doi: 10.1016/j.ejcb.2009.11.026. Epub 2010 Mar 12. Review.

PMID:
20227133
4.

Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.

van Kilsdonk JW, Wilting RH, Bergers M, van Muijen GN, Schalkwijk J, van Kempen LC, Swart GW.

Cancer Res. 2008 May 15;68(10):3671-9. doi: 10.1158/0008-5472.CAN-07-5767.

5.

Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma.

van Kempen LC, Rijntjes J, Mamor-Cornelissen I, Vincent-Naulleau S, Gerritsen MJ, Ruiter DJ, van Dijk MC, Geffrotin C, van Muijen GN.

Int J Cancer. 2008 Mar 1;122(5):1019-29.

6.

Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes.

Weijenberg MP, Lüchtenborg M, de Goeij AF, Brink M, van Muijen GN, de Bruïne AP, Goldbohm RA, van den Brandt PA.

Cancer Causes Control. 2007 Oct;18(8):865-79. Epub 2007 Jul 18.

7.

Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.

Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, Kok FJ, Kampman E.

Clin Gastroenterol Hepatol. 2007 Jun;5(6):736-42.

PMID:
17544999
8.

In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients.

De Vries IJ, Bernsen MR, van Geloof WL, Scharenborg NM, Lesterhuis WJ, Rombout PD, Van Muijen GN, Figdor CG, Punt CJ, Ruiter DJ, Adema GJ.

Cancer Immunol Immunother. 2007 Oct;56(10):1667-76. Epub 2007 Apr 18.

PMID:
17440724
9.

Melanoma progression in a changing environment.

van Kempen LC, van Muijen GN, Ruiter DJ.

Eur J Cell Biol. 2007 Feb;86(2):65-7. Epub 2007 Jan 22. Review. No abstract available.

PMID:
17241688
10.

Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas.

Wark PA, Van der Kuil W, Ploemacher J, Van Muijen GN, Mulder CJ, Weijenberg MP, Kok FJ, Kampman E.

Int J Cancer. 2006 Jul 15;119(2):398-405.

11.

Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage.

De Raeve LE, Claes A, Ruiter DJ, van Muijen GN, Roseeuw D, van Kempen LC.

Br J Dermatol. 2006 Mar;154(3):485-92.

PMID:
16445780
12.

Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.

Lüchtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen GM, van Muijen GN, de Bruïne AP, van den Brandt PA, de Goeij AF.

BMC Cancer. 2005 Dec 15;5:160.

13.

Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.

Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, Willems PH, van Muijen GN, Swart GW.

Cancer Res. 2005 Oct 1;65(19):8801-8.

14.

Fruits, vegetables, and hMLH1 protein-deficient and -proficient colon cancer: The Netherlands cohort study.

Wark PA, Weijenberg MP, van 't Veer P, van Wijhe G, Lüchtenborg M, van Muijen GN, de Goeij AF, Goldbohm RA, van den Brandt PA.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1619-25.

15.

Stromal responses in human primary melanoma of the skin.

van Kempen LC, van Muijen GN, Ruiter DJ.

Front Biosci. 2005 Sep 1;10:2922-31. Review.

PMID:
15970546
16.

Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays.

de Wit NJ, Rijntjes J, Diepstra JH, van Kuppevelt TH, Weidle UH, Ruiter DJ, van Muijen GN.

Br J Cancer. 2005 Jun 20;92(12):2249-61.

17.

Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms.

Lüchtenborg M, Weijenberg MP, Kampman E, van Muijen GN, Roemen GM, Zeegers MP, Goldbohm RA, van 't Veer P, de Goeij AF, van den Brandt PA.

Am J Epidemiol. 2005 May 1;161(9):806-15.

PMID:
15840612
18.

Testis-specific human small heat shock protein HSPB9 is a cancer/testis antigen, and potentially interacts with the dynein subunit TCTEL1.

de Wit NJ, Verschuure P, Kappé G, King SM, de Jong WW, van Muijen GN, Boelens WC.

Eur J Cell Biol. 2004 Aug;83(7):337-45.

PMID:
15503857
19.

Differential patterns of insulin-like growth factor-I and -II mRNA expression in medulloblastoma.

van Doorn J, Gilhuis HJ, Koster JG, Wesseling P, Reddingius RE, Gresnigt MG, Bloemen RJ, van Muijen GN, van Buul-Offers SC.

Neuropathol Appl Neurobiol. 2004 Oct;30(5):503-12.

PMID:
15488026
20.

Type I collagen synthesis parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell carcinoma.

van Kempen LC, Rijntjes J, Claes A, Blokx WA, Gerritsen MJ, Ruiter DJ, van Muijen GN.

J Pathol. 2004 Nov;204(3):333-9.

PMID:
15476275
21.

The MMA1 gene family of cancer-testis antigens has multiple alternative splice variants: characterization of their expression profile, the genomic organization, and transcript properties.

de Wit NJ, Cornelissen IM, Diepstra JH, Weidle UH, Ruiter DJ, van Muijen GN.

Genes Chromosomes Cancer. 2005 Jan;42(1):10-21.

PMID:
15472897
22.

Dietary factors and truncating APC mutations in sporadic colorectal adenomas.

Diergaarde B, Tiemersma EW, Braam H, van Muijen GN, Nagengast FM, Kok FJ, Kampman E.

Int J Cancer. 2005 Jan 1;113(1):126-32.

23.

Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n.

ten Dam GB, van de Westerlo EM, Smetsers TF, Willemse M, van Muijen GN, Merry CL, Gallagher JT, Kim YS, van Kuppevelt TH.

J Biol Chem. 2004 Sep 10;279(37):38346-52. Epub 2004 Jul 7.

24.

Immunohistochemistry in melanocytic proliferative lesions.

de Wit NJ, van Muijen GN, Ruiter DJ.

Histopathology. 2004 Jun;44(6):517-41. Review.

PMID:
15186267
25.

Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.

van Kempen LC, Meier F, Egeblad M, Kersten-Niessen MJ, Garbe C, Weidle UH, Van Muijen GN, Herlyn M, Bloemers HP, Swart GW.

J Invest Dermatol. 2004 May;122(5):1293-301.

26.

Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis.

Smetsers TF, van de Westerlo EM, ten Dam GB, Overes IM, Schalkwijk J, van Muijen GN, van Kuppevelt TH.

J Invest Dermatol. 2004 Mar;122(3):707-16.

27.

Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.

Bartolomé RA, Gálvez BG, Longo N, Baleux F, Van Muijen GN, Sánchez-Mateos P, Arroyo AG, Teixidó J.

Cancer Res. 2004 Apr 1;64(7):2534-43.

28.

The tumor microenvironment: a critical determinant of neoplastic evolution.

van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM.

Eur J Cell Biol. 2003 Nov;82(11):539-48. Review.

PMID:
14703010
29.
30.

Dietary factors and microsatellite instability in sporadic colon carcinomas.

Diergaarde B, Braam H, van Muijen GN, Ligtenberg MJ, Kok FJ, Kampman E.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1130-6.

31.

Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer.

Vlems FA, Diepstra JH, Punt CJ, Ligtenberg MJ, Cornelissen IM, van Krieken JH, Wobbes T, van Muijen GN, Ruers TJ.

Br J Surg. 2003 Aug;90(8):989-95.

PMID:
12905553
32.

Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma.

Smetsers TF, van de Westerlo EM, ten Dam GB, Clarijs R, Versteeg EM, van Geloof WL, Veerkamp JH, van Muijen GN, van Kuppevelt TH.

Cancer Res. 2003 Jun 1;63(11):2965-70.

33.

The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines.

Zendman AJ, Zschocke J, van Kraats AA, de Wit NJ, Kurpisz M, Weidle UH, Ruiter DJ, Weiss EH, van Muijen GN.

Gene. 2003 May 8;309(2):125-33.

PMID:
12758128
34.

Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective.

Vlems FA, Ruers TJ, Punt CJ, Wobbes T, van Muijen GN.

Eur J Surg Oncol. 2003 May;29(4):289-302. Review.

PMID:
12711279
35.

Cryosurgery of tumor tissue causes endotoxin tolerance through an inflammatory response.

Joosten JJ, van Muijen GN, Wobbes T, Ruers TJ.

Anticancer Res. 2003 Jan-Feb;23(1A):427-32.

PMID:
12680243
36.

Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection.

Vlems FA, Diepstra JH, Cornelissen IM, Ligtenberg MJ, Wobbes T, Punt CJ, van Krieken JH, Ruers TJ, van Muijen GN.

Anticancer Res. 2003 Jan-Feb;23(1A):179-86.

PMID:
12680210
37.

Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.

Vlems FA, Wobbes T, Punt CJ, Van Muijen GN.

Anticancer Res. 2003 Jan-Feb;23(1B):523-30. Review.

PMID:
12680140
38.

Cigarette smoking and genetic alterations in sporadic colon carcinomas.

Diergaarde B, Vrieling A, van Kraats AA, van Muijen GN, Kok FJ, Kampman E.

Carcinogenesis. 2003 Mar;24(3):565-71.

PMID:
12663519
39.

Dietary factors and the occurrence of truncating APC mutations in sporadic colon carcinomas: a Dutch population-based study.

Diergaarde B, van Geloof WL, van Muijen GN, Kok FJ, Kampman E.

Carcinogenesis. 2003 Feb;24(2):283-90.

PMID:
12584179
40.

Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol.

Vlems FA, Ladanyi A, Gertler R, Rosenberg R, Diepstra JH, Röder C, Nekarda H, Molnar B, Tulassay Z, van Muijen GN, Vogel I.

Eur J Cancer. 2003 Feb;39(3):388-96.

PMID:
12565993
41.

Cancer/testis-associated genes: identification, expression profile, and putative function.

Zendman AJ, Ruiter DJ, Van Muijen GN.

J Cell Physiol. 2003 Mar;194(3):272-88. Review.

PMID:
12548548
42.

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, Strijk SP, Ruers TJ, Boerman OC, Oyen WJ, Adema GJ, Punt CJ, Figdor CG.

Cancer Res. 2003 Jan 1;63(1):12-7.

43.

Diet and truncating APC mutations in sporadic colon tumours.

Diergaarde B, van Geloof WL, van Muijen GN, Kok FJ, Kampman E.

IARC Sci Publ. 2002;156:505-6. No abstract available.

PMID:
12484245
44.

Dietary factors, genetic susceptibility and somatic mutations in colorectal cancer: a prospective study.

Weijenberg MP, Brink M, Lüchtenborg M, Wark PA, de Goeij AF, de Bruïne AP, van't Veer P, Kampman E, van Muijen GN, Goldbohm RA, van den Brandt PA.

IARC Sci Publ. 2002;156:503-4. No abstract available.

PMID:
12484244
45.

Spitz naevi may express components of the plasminogen activation system.

Ferrier CM, Van Geloof WL, Straatman H, Van De Molengraft FJ, Van Muijen GN, Ruiter DJ.

J Pathol. 2002 Sep;198(1):92-9.

PMID:
12210068
46.

Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.

Vlems FA, Diepstra JH, Cornelissen IM, Ruers TJ, Ligtenberg MJ, Punt CJ, van Krieken JH, Wobbes T, van Muijen GN.

Mol Pathol. 2002 Jun;55(3):156-63.

47.

The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma.

Zendman AJ, Van Kraats AA, Weidle UH, Ruiter DJ, Van Muijen GN.

Int J Cancer. 2002 May 20;99(3):361-9.

48.

Expression profiling of MMA-1a and splice variant MMA-1b: new cancer/testis antigens identified in human melanoma.

de Wit NJ, Weidle UH, Ruiter DJ, van Muijen GN.

Int J Cancer. 2002 Apr 1;98(4):547-53.

49.

Tumour metastasis: is tissue an issue?

Ruiter DJ, van Krieken JH, van Muijen GN, de Waal RM.

Lancet Oncol. 2001 Feb;2(2):109-12. Review.

PMID:
11905791
50.

Human single chain antibodies against heparin: selection, characterization, and effect on coagulation.

van de Westerlo EM, Smetsers TF, Dennissen MA, Linhardt RJ, Veerkamp JH, van Muijen GN, van Kuppevelt TH.

Blood. 2002 Apr 1;99(7):2427-33.

PMID:
11895775

Supplemental Content

Loading ...
Support Center